Movement Alert｜Liquidia Technologies Falls 5.37% in Regular Trading, BofA Securities Downgrades Rating to Neutral

Market Focus06-29

On June 29, Liquidia Technologies fell 5.37% in regular trading, trading at $73.09/share, with turnover of approximately $31.95 million.

On the news front, BofA Securities downgraded Liquidia from Buy to Neutral, setting a price target of $79. The stock had risen in pre-market trading on strong YUTREPIA commercialization momentum and upcoming poster presentations at the PHA International PH Conference, but the downgrade triggered profit-taking pressure during regular hours.

Fundamentally, the company reported robust Q1 results with EPS of $0.52, beating the consensus estimate of $0.41 by approximately 27%. YUTREPIA net product sales reached roughly $130 million with over 4,500 unique patient prescriptions, marking a swing to profitability from a loss of $0.45 per share in the year-ago quarter. Despite the strong operational performance, the downgrade suggests current valuations may have fully priced in near-term catalysts, limiting further upside potential.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1115876853?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-29 22:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115876853","market":"us","top_or_hot":-1,"title":"Movement Alert｜Liquidia Technologies Falls 5.37% in Regular Trading, BofA Securities Downgrades Rating to Neutral","media":"Market Focus","content":"<p><p>On June 29, Liquidia Technologies fell 5.37% in regular trading, trading at $73.09/share, with turnover of approximately $31.95 million.</p><p>On the news front, BofA Securities downgraded Liquidia from Buy to Neutral, setting a price target of $79. The stock had risen in pre-market trading on strong YUTREPIA commercialization momentum and upcoming poster presentations at the PHA International PH Conference, but the downgrade triggered profit-taking pressure during regular hours.</p><p>Fundamentally, the company reported robust Q1 results with EPS of $0.52, beating the consensus estimate of $0.41 by approximately 27%. YUTREPIA net product sales reached roughly $130 million with over 4,500 unique patient prescriptions, marking a swing to profitability from a loss of $0.45 per share in the year-ago quarter. Despite the strong operational performance, the downgrade suggests current valuations may have fully priced in near-term catalysts, limiting further upside potential.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Liquidia Technologies Falls 5.37% in Regular Trading, BofA Securities Downgrades Rating to Neutral</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Liquidia Technologies Falls 5.37% in Regular Trading, BofA Securities Downgrades Rating to Neutral\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-29 22:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 29, Liquidia Technologies fell 5.37% in regular trading, trading at $73.09/share, with turnover of approximately $31.95 million.</p><p>On the news front, BofA Securities downgraded Liquidia from Buy to Neutral, setting a price target of $79. The stock had risen in pre-market trading on strong YUTREPIA commercialization momentum and upcoming poster presentations at the PHA International PH Conference, but the downgrade triggered profit-taking pressure during regular hours.</p><p>Fundamentally, the company reported robust Q1 results with EPS of $0.52, beating the consensus estimate of $0.41 by approximately 27%. YUTREPIA net product sales reached roughly $130 million with over 4,500 unique patient prescriptions, marking a swing to profitability from a loss of $0.45 per share in the year-ago quarter. Despite the strong operational performance, the downgrade suggests current valuations may have fully priced in near-term catalysts, limiting further upside potential.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LQDA","symbol_name":"Liquidia Technologies Inc","start_time":0,"source_url":"","article_id":"1115876853","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115876853","pubTimestamp":1782742222,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 29, Liquidia Technologies fell 5.37% in regular trading, trading at $73.09/share, with turnover of approximately $31.95 million.On the news front, BofA Securities downgraded Liquidia from Buy...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LQDA":"Liquidia Technologies Inc"},"translate_title":"动向提示|Liquidia Technologies常规交易下跌5.37%美银证券下调评级至中性","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LQDA":1},"content_text":"On June 29, Liquidia Technologies fell 5.37% in regular trading, trading at $73.09/share, with turnover of approximately $31.95 million.On the news front, BofA Securities downgraded Liquidia from Buy to Neutral, setting a price target of $79. The stock had risen in pre-market trading on strong YUTREPIA commercialization momentum and upcoming poster presentations at the PHA International PH Conference, but the downgrade triggered profit-taking pressure during regular hours.Fundamentally, the company reported robust Q1 results with EPS of $0.52, beating the consensus estimate of $0.41 by approximately 27%. YUTREPIA net product sales reached roughly $130 million with over 4,500 unique patient prescriptions, marking a swing to profitability from a loss of $0.45 per share in the year-ago quarter. Despite the strong operational performance, the downgrade suggests current valuations may have fully priced in near-term catalysts, limiting further upside potential.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1115876853","isCrawlerRequest":true}